Sanderson McLeod Recruits Ellen Sheets for CSA Medical

Medical Device Industry Leader moves from larger company to surgical Innovator with a proprietary interventional spray cryotherapy technology platform.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Baltimore, MD (PRWEB) August 12, 2012

Sanderson McLeod announced the hiring of Ellen Sheets for CSA Medical.“Ellen Sheets has a proven history of success with fast growing companies. She will be a very strong strategic addition to the executive team at CSA as they work to expand the company’s clinical applications.” stated Paul Sanderson.

Sheets brings to the company a broad range of experience within the medical diagnostic, device and pharmaceutical industries as well as more than 15 years in clinical and academic positions at Brigham and Women’s Hospital/Harvard Medical School. Prior to joining CSA Medical, she served as Chief Medical Officer and Vice President of North American R&D at QIAGEN, Inc. where she led product development, clinical trial and constituency relations programs in developing novel diagnostic markers and instrument platforms. Previously, she served as Chief Medical Officer at Predictive Biosciences, where she was instrumental in raising over $45 million in venture support. From 2002-2008, Sheets was Chief Medical Officer at Hologic Inc. (previously Cytyc Corporation), where she was responsible for medical education, clinical trials, advocacy, government affairs and reimbursement strategies. In this position she directly contributed to identifying and acquiring opportunities that grew top line revenue from $250M to over $750M. She earned bachelor of science and doctorate of medicine degrees from the University of Michigan and a master’s degree in Business Administration from New York University.

About CSA Medical
CSA Medical, Inc. develops and manufactures a proprietary interventional spray cryotherapy technology platform comprised of a device and specialty catheters that enable delivery of spray cryogen inside the body to flash freeze and destroy diseased tissue. The Company is the first to harness the power of low pressure, extremely cold (-196 o C) liquid nitrogen inside the body. For more information please visit http://www.CSAmedical.com

About Sanderson McLeod

Sanderson McLeod is a boutique agency specializing in Executive Search for Venture funded and high growth companies. With clients in biotech, medical device, software, and clean technology, the firm has a history in “finding the fit.” Great leaps in innovation start with small – midsize companies led by courageous entrepreneurs. Sanderson McLeod’s mission is to help these companies find and hire the talent that will make sure they have the best chance at reaching their goals.


Contact

  • Paul Sanderson
    Sanderson McLeod
    (615) 260-3205
    Email

Past News Releases Group Rss Subscribe